Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 90Breast Neoplasms 87Carcinoma, Non-Small-Cell Lung 33Triple Negative Breast Neoplasms 22Squamous Cell Carcinoma of Head and Neck 19Neoplasms 18Neoplasm Metastasis 18Ovarian Neoplasms 17Stomach Neoplasms 15Lung Neoplasms 13Head and Neck Neoplasms 11Esophageal Squamous Cell Carcinoma 10Esophageal Neoplasms 10Cholangiocarcinoma 10Recurrence 9Melanoma 8Small Cell Lung Carcinoma 7Sarcoma 7Pancreatic Adenocarcinoma 7Inflammatory Breast Neoplasms 7Breast Neoplasms, Male 7Adenocarcinoma 7Prostatic Neoplasms 6Fallopian Tube Neoplasms 6Urinary Bladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Biliary Tract Neoplasms 5Uterine Cervical Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Ductal, Breast 4

Interventions

Cisplatin 3anlotinib 2Sunitinib 2Radiotherapy, Intensity-Modulated 2Gemcitabine 2Carboplatin 2olaparib 1niraparib 1ixabepilone 1Taxes 1Sorafenib 1Radiofrequency Ablation 1Paclitaxel 1Nimorazole 1Irinotecan 1Filgrastim 1Endoscopic Mucosal Resection 1Cobicistat 1Chemoradiotherapy 1Capecitabine 1CP protocol 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Glandular and Epithelial × Albumin-Bound Paclitaxel × Clear all
NCT03535727 2024-12-31

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
48 enrolled 24 charts
Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡